Federal contract award
15B10626P00000087
ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC BUTNER |
| NAICS | 524292 — Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $115.7K |
| Current contract value | $115.7K |
| Potential contract value / ceiling | $115.7K |
| Start date | Nov 12, 2025 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Feb 18, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 18, 2026 | P00002 | $66.8K | ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE |
| Dec 1, 2025 | P00001 | $48.9K | ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE |
| Nov 12, 2025 | 0 | $0 | ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.